Olopatadine Hydrochloride Solution
NDC Package 76162-044-39
Package Information
Olopatadine Hydrochloride solution is adults and children 2 years of age and older:put 1 drop in the affected eye(s) once daily, no more than once per dayif using other ophthalmic products while using this product, wait at least 5 minutes between each productreplace cap after each usechildren under 2 years of age: consult a doctor. This formulation utilizes a solution delivery system. Marketed by Topco Associates Llc, this product is identified by NDC 76162-044 and is authorized under FDA application ANDA209995.
Identification & Billing
- RxCUI: 1111343 - olopatadine HCl 0.2 % Ophthalmic Solution
- RxCUI: 1111343 - olopatadine 2 MG/ML Ophthalmic Solution
- RxCUI: 1111343 - olopatadine 0.2 % Ophthalmic Solution
- RxCUI: 1111343 - olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution
Clinical Specifications
- Decreased Histamine Release - [PE] (Physiologic Effect)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Histamine-1 Receptor Inhibitor - [EPC] (Established Pharmacologic Class)
- Mast Cell Stabilizer - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 76162 - Topco Associates Llc
- 76162-044 - Olopatadine Hydrochloride
- 76162-044-39 - 1 BOTTLE, PLASTIC in 1 CARTON / 2.5 mL in 1 BOTTLE, PLASTIC
- 76162-044 - Olopatadine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76162-044-39 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 2.5 ml in 1 bottle, plastic of Olopatadine Hydrochloride, a human over the counter drug labeled by Topco Associates Llc. This solution is formulated for ophthalmic use and contains olopatadine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Topco Associates Llc on July 15, 2020. The current certification is valid through December 31, 2026.
How is this Topco Associates Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76162004439. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.